Literature DB >> 21240680

Two case reports of inherited antithrombin deficiency: a novel frameshift mutation and a large deletion including all seven exons detected using two methods.

Akiko Sekiya1, Eriko Morishita2,3, Megumi Karato1, Keiko Maruyama1, Itsumi Shimogawara1, Mika Omote4, Yoshiyuki Wakugawa5, Moeko Shinohara6, Tomoe Hayashi7, Yasuko Kadohira7, Hidesaku Asakura7, Shinji Nakao7, Shigeki Ohtake1,7.   

Abstract

An inherited antithrombin deficiency is an autosomal dominant thrombotic disorder. We identified two pedigrees of inherited type I antithrombin deficiency and two responsible mutations in each. A novel 21-22delAA appeared to have caused a frameshift with a premature termination at amino acid +63 in one patient and a large deletion including all seven exons was identified by multiplex ligation-dependent probe amplification in the other. Some asymptomatic relatives of the second patient had the same mutation. The present findings support the value of using more than one method of gene analysis and of studying the families of probands with inherited thrombotic disorders.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21240680     DOI: 10.1007/s12185-010-0763-x

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  11 in total

1.  Relative quantification of 40 nucleic acid sequences by multiplex ligation-dependent probe amplification.

Authors:  Jan P Schouten; Cathal J McElgunn; Raymond Waaijer; Danny Zwijnenburg; Filip Diepvens; Gerard Pals
Journal:  Nucleic Acids Res       Date:  2002-06-15       Impact factor: 16.971

2.  Identification of the novel signal peptide mutation, antithrombin-Siriraj causes type-I antithrombin deficiency in thai patients.

Authors:  Yingyong Chinthammitr; Worrawut Chinchang; Theera Ruchutrakool; Vip Viprakasit
Journal:  Thromb Haemost       Date:  2005-09       Impact factor: 5.249

3.  Recommendations for a nomenclature system for human gene mutations. Nomenclature Working Group.

Authors:  S E Antonarakis
Journal:  Hum Mutat       Date:  1998       Impact factor: 4.878

4.  The incidence of venous thromboembolism in asymptomatic carriers of a deficiency of antithrombin, protein C, or protein S: a prospective cohort study.

Authors:  B J Sanson; P Simioni; D Tormene; M Moia; P W Friederich; M V Huisman; P Prandoni; A Bura; L Rejto; P Wells; P M Mannucci; A Girolami; H R Büller; M H Prins
Journal:  Blood       Date:  1999-12-01       Impact factor: 22.113

5.  A prospective cohort study on the absolute risks of venous thromboembolism and predictive value of screening asymptomatic relatives of patients with hereditary deficiencies of protein S, protein C or antithrombin.

Authors:  B K Mahmoodi; J-L P Brouwer; M K Ten Kate; W M Lijfering; N J G M Veeger; A B Mulder; H C Kluin-Nelemans; J Van Der Meer
Journal:  J Thromb Haemost       Date:  2010-03-04       Impact factor: 5.824

6.  Usefulness of antithrombin deficiency phenotypes for risk assessment of venous thromboembolism: type I deficiency as a strong risk factor for venous thromboembolism.

Authors:  Mana Mitsuguro; Toshiyuki Sakata; Akira Okamoto; Sachika Kameda; Yoshihiro Kokubo; Yoshiaki Tsutsumi; Michitaka Sano; Toshiyuki Miyata
Journal:  Int J Hematol       Date:  2010-09-23       Impact factor: 2.490

7.  Risk of a first venous thrombotic event in carriers of a familial thrombophilic defect. The European Prospective Cohort on Thrombophilia (EPCOT).

Authors:  C Y Vossen; J Conard; J Fontcuberta; M Makris; F J M VAN DER Meer; I Pabinger; G Palareti; F E Preston; I Scharrer; J C Souto; P Svensson; I D Walker; F R Rosendaal
Journal:  J Thromb Haemost       Date:  2005-03       Impact factor: 5.824

Review 8.  Molecular genetics of antithrombin deficiency.

Authors:  D A Lane; G Kunz; R J Olds; S L Thein
Journal:  Blood Rev       Date:  1996-06       Impact factor: 8.250

9.  Detection and characterisation of large SERPINC1 deletions in type I inherited antithrombin deficiency.

Authors:  Véronique Picard; Jian-Min Chen; Brigitte Tardy; Marie-Françoise Aillaud; Christine Boiteux-Vergnes; Marie Dreyfus; Joseph Emmerich; Cécile Lavenu-Bombled; Ulrike Nowak-Göttl; Nathalie Trillot; Martine Aiach; Martine Alhenc-Gelas
Journal:  Hum Genet       Date:  2009-09-17       Impact factor: 4.132

10.  Complete nucleotide sequence of the antithrombin gene: evidence for homologous recombination causing thrombophilia.

Authors:  R J Olds; D A Lane; V Chowdhury; V De Stefano; G Leone; S L Thein
Journal:  Biochemistry       Date:  1993-04-27       Impact factor: 3.162

View more
  3 in total

1.  Causative genetic mutations for antithrombin deficiency and their clinical background among Japanese patients.

Authors:  Akiko Sekiya; Fumina Taniguchi; Daisuke Yamaguchi; Sayaka Kamijima; Shonosuke Kaneko; Shiori Katsu; Miho Hanamura; Mao Takata; Haruka Nakano; Hidesaku Asakura; Shigeki Ohtake; Eriko Morishita
Journal:  Int J Hematol       Date:  2016-11-17       Impact factor: 2.490

2.  A complex genomic abnormality found in a patient with antithrombin deficiency and autoimmune disease-like symptoms.

Authors:  Io Kato; Yuki Takagi; Yumi Ando; Yuki Nakamura; Moe Murata; Akira Takagi; Takashi Murate; Tadashi Matsushita; Tadaaki Nakashima; Tetsuhito Kojima
Journal:  Int J Hematol       Date:  2014-06-03       Impact factor: 2.490

3.  Antithrombin III deficiency in Indian patients with deep vein thrombosis: identification of first India based AT variants including a novel point mutation (T280A) that leads to aggregation.

Authors:  Teena Bhakuni; Amit Sharma; Qudsia Rashid; Charu Kapil; Renu Saxena; Manoranjan Mahapatra; Mohamad Aman Jairajpuri
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.